Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: LATUDA

« Back to Dashboard

Summary for Tradename: LATUDA

Patents:2
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: LATUDA

Clinical Trials for: LATUDA

Lurasidone Low-Dose - High-Dose Study Study
Status: Completed Condition: Schizophrenia

Lurasidone Effects on Tissue Glutamate in Schizophrenia
Status: Recruiting Condition: Schizophrenia; Schizoaffective Disorder

A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects
Status: Completed Condition: Schizophrenia

Lurasidone Pediatric Autism Study
Status: Active, not recruiting Condition: Autism

Lurasidone Pediatric Pharmacokinetics Study
Status: Completed Condition: Schizophrenia; Autism

Pediatric Schizophrenia Efficacy and Safety Study
Status: Recruiting Condition: Schizophrenia

Lurasidone and Cognition in Bipolar I Disorder
Status: Recruiting Condition: Bipolar I Disorder

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Status: Completed Condition: Schizophrenia; Schizoaffective Disorder

RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE
Status: Completed Condition: Pharmacokinetics; Metabolism

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Completed Condition: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Psychosis NOS; Autistic Disorder; Asperger Syndrome; Child Development Disorders, Pervasive; Bipolar I Disorder; Bipolar II Disorder; Mood Disorder NOS; Severe Major Depression With Psychotic Features; Single Episode Major Depression Without Psychotic Symptoms; Severe Mood Disorder With Psychotic Features

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc
LATUDA
lurasidone hydrochloride
TABLET;ORAL200603Oct 28, 2010RXNo5,532,372<disabled>Y<disabled>
Sunovion Pharms Inc
LATUDA
lurasidone hydrochloride
TABLET;ORAL200603Jul 12, 2013RXNo<disabled><disabled>
Sunovion Pharms Inc
LATUDA
lurasidone hydrochloride
TABLET;ORAL200603Jul 12, 2013RXNo5,532,372<disabled>Y<disabled>
Sunovion Pharms Inc
LATUDA
lurasidone hydrochloride
TABLET;ORAL200603Dec 7, 2011RXNo8,729,085<disabled>Y<disabled>
Sunovion Pharms Inc
LATUDA
lurasidone hydrochloride
TABLET;ORAL200603Apr 26, 2012RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc